Chronic Kidney Disease (CKD) is a condition characterized by the progressive deterioration of kidney function. It typically develops slowly, with subtle early symptoms, but if left untreated, it can eventually lead to kidney failure requiring lifelong treatments such as dialysis or kidney transplantation. According to statistics from the World Health Organization, the prevalence of CKD is increasing worldwide, making it a serious public health issue.
The primary functions of the kidneys include filtering waste products from the blood, regulating fluid balance, and maintaining electrolyte stability. CKD leads to the gradual loss of these functions, impacting overall health. Diagnosis and treatment involve blood tests, urine analysis, and imaging studies. Early detection can effectively slow disease progression. This article provides a comprehensive overview of CKD, including causes, symptoms, diagnostic methods, treatment options, and prevention strategies.
The causes of CKD are complex and often stem from long-standing health issues. The most common causes are diabetes and hypertension, which damage the microvasculature of the glomeruli, impairing filtration function. Diabetic patients with prolonged hyperglycemia experience sclerosis of the glomerular filtration membrane, a process known as diabetic nephropathy, accounting for about 40% of CKD cases. Hypertension causes sustained high blood pressure, leading to abnormal renal hemodynamics and further glomerular damage.
Genetic factors and other diseases can also increase risk. For example, hereditary conditions like polycystic kidney disease directly damage kidney structure; autoimmune diseases such as systemic lupus erythematosus can cause renal inflammation. Additionally, long-term use of pain medications, recurrent urinary tract infections, or kidney stones can gradually impair renal function. Aging is also a significant risk factor, with individuals over 60 experiencing natural renal decline and higher susceptibility.
Early symptoms of CKD are often mild, such as slight fatigue or changes in urination habits. As the disease progresses to stage three, symptoms become more apparent, including periorbital edema in the morning, lower limb swelling, darkened urine or foamy urine. Severe cases may present with symptoms of waste accumulation, such as skin itching, shortness of breath, and indigestion.
Patients may experience metabolic disturbances, such as osteoporosis due to calcium-phosphate metabolism abnormalities or dizziness and concentration issues from anemia. In late stages, symptoms like cardiomegaly and arrhythmias may occur, indicating systemic metabolic imbalance. Notably, about 30% of patients may have no obvious symptoms during the course of the disease, and detection relies on medical examinations.
The diagnosis of CKD mainly depends on blood and urine tests. Serum creatinine levels are used to calculate the estimated glomerular filtration rate (eGFR), which should be above 60 mL/min/1.73m². Persistent proteinuria or hematuria in urine tests are important indicators; a 24-hour urine protein excretion exceeding 300 mg is abnormal.
Imaging studies such as ultrasound can observe kidney size, structural abnormalities, or obstructions. Renal biopsy remains the gold standard for determining the type of pathology, distinguishing between immune-related nephritis and vascular lesions. Physicians typically classify CKD into stages (G1-G5) based on the progression of renal function to guide treatment planning, with staging criteria based on eGFR and symptom severity.
The main focus of CKD treatment is controlling underlying conditions and slowing disease progression. Diabetic patients should strictly control blood glucose levels, aiming for HbA1c below 7%, with regular monitoring of renal function. Hypertensive patients should use renin-angiotensin system blockers (such as ACE inhibitors or ARBs), which not only lower blood pressure but also provide direct renal protection.
Different stages of renal function require tailored strategies. Early stages (before stage 3) focus on medication to control metabolic indicators; stages 4 and 5 require preparation for dialysis or transplantation and dietary restrictions on sodium, phosphorus, and protein intake. Nutritional therapy involves adjusting protein, potassium, and sodium intake based on eGFR—for example, limiting protein to 0.8 grams per kilogram of body weight when eGFR falls below 30 mL/min.
Prevention of CKD begins with controlling underlying diseases. Diabetic patients should maintain blood glucose within target ranges through medication and diet, with regular urine albumin testing. Hypertensive patients should keep systolic blood pressure below 130/80 mmHg and avoid nephrotoxic NSAIDs.
A healthy diet is crucial for kidney protection. It is recommended to adopt a low-salt, low-fat diet with adequate high-quality protein sources such as fish and skinless poultry. Increasing dietary fiber can improve metabolism, but high-potassium foods like bananas and spinach should be avoided in cases of impaired renal function. Quitting smoking reduces the risk of renal ischemia; studies show that smokers experience faster renal decline, at 1.5 times the rate of non-smokers.
Seek immediate medical attention if you experience: significant swelling of eyelids or ankles in the morning, darkened urine or hematuria, unexplained weight gain with shortness of breath. Even without symptoms, regular screening is recommended for those who meet the following criteria: over 60 years old, with a history of diabetes for more than 5 years, or with a family history of kidney disease.
If urine tests show a persistent albumin-to-creatinine ratio above 30 mg/g or eGFR remains below 60 mL/min for more than three months, a diagnosis of CKD is established, and a nephrologist should develop an individualized treatment plan. Follow-up intervals depend on disease severity, typically every 3-6 months for repeat renal function tests.
CKD patients should limit high-protein, high-sodium, and high-phosphorus foods to reduce kidney burden. It is recommended to choose high-quality protein sources such as fish and skinless poultry, and avoid excessive intake of caffeinated or high-potassium beverages. Fluid intake should be adjusted based on renal function to prevent edema or waste accumulation.
What are the benefits and precautions of regular exercise for CKD patients?Moderate exercise can help control blood pressure, blood sugar, and weight, thereby delaying disease progression. Low to moderate intensity activities like walking or swimming are recommended, but strenuous activities should be avoided. Patients should consult their doctor before exercising, especially if they have hypertension or severe renal impairment, to adjust exercise intensity and avoid risks.
How should CKD patients avoid drug-induced kidney damage when taking other medications?Some pain relievers (such as ibuprofen) and antibiotics can worsen kidney damage. Patients should inform their healthcare provider of their condition before taking new medications, avoid self-medicating, and ensure drug safety for the kidneys. Regular monitoring of serum creatinine and urine indicators is essential to ensure appropriate dosing.
What early symptoms of CKD are often overlooked?Early signs may include nocturia, eyelid swelling, unexplained fatigue, or concentration issues. These symptoms are often mistaken for fatigue or aging. Regular testing of urine protein and serum creatinine is recommended, especially for those with hypertension or diabetes.
How can lifestyle modifications reduce the risk of CKD?Controlling blood pressure below 130/80 mmHg, maintaining HbA1c below 7%, and quitting smoking can significantly reduce risk. Reducing processed food intake, increasing fruit and vegetable consumption, and regular renal screening are also advised, especially for those with a family history or over 60 years old.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
